Related Experiment Video
Updated: Jul 16, 2026
05:57
Fission Yeast as a Platform for Antibacterial Drug Screens Targeting Bacterial Cytoskeleton Proteins
Published on: April 26, 2024
Focus on Fotemustine
A De Rossi1, L Rossi, A Laudisi
1Department of Neuroscience, University of Rome "Tor Vergata", Italy.
Journal of Experimental & Clinical Cancer Research : CR
|February 22, 2007
Summary
Fotemustine, a nitrosourea alkylating agent, demonstrates antitumor activity and acceptable toxicity. Its potential role in treating hematological malignancies is suggested due to its mechanism and pharmacodynamic properties.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- Fotemustine is a cytotoxic alkylating agent from the nitrosourea family.
- Its mechanism involves mono-functional/bi-functional DNA alkylation.
- Drug resistance can arise from high levels of O6-methylguanine-DNA-methyltransferase (MGMT).
Purpose of the Study:
- To review the antitumor activity, toxicity, and potential applications of Fotemustine.
- To explore Fotemustine's suitability for hematological malignancies.
Main Methods:
- Review of clinical trial data.
- Analysis of Fotemustine's pharmacokinetic and pharmacodynamic properties.
- Comparison with other alkylating agents like Temozolomide.
Main Results:
- Fotemustine exhibits significant antitumor activity as a single agent and in combination therapies.
- Its toxicity profile is generally acceptable.
- The drug has been used for metastatic melanoma and brain tumors.
Conclusions:
- Fotemustine shows promise for treating hematological malignancies, particularly acute refractory leukemia, based on its properties.
- Further investigation into its role in blood cancers is warranted.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...